Christina Mattina

James R. Jett, MD, gave an overview of the advances in diagnosis and treatment of non–small cell lung cancer (NSCLC) during a session at the National Association of Managed Care Physicians Fall Managed Care Forum 2017.

Industries including healthcare continue to adapt to the increasingly powerful voice of the consumer, according to Venkat Inumella, MBA, associate partner at McKinsey, who discussed this trend toward consumerism during the first keynote session of the National Association of Managed Care Physicians Fall Managed Care Forum 2017.

At the National Association of Managed Care Physicians Fall Managed Care Forum 2017, James J. Bleicher, MD, MHCM, regional president of SSM Health, discussed the foundational steps necessary for healthcare organizations looking to transform their business to focus on population health.

At this year's Academy of Managed Care Pharmacy (AMCP) Nexus conference, a few trending topics resurfaced across the meeting's agenda, with important implications for pharmacists, payers, and beyond.

Inviting patients to share their own health data can result in a better understanding of diseases and treatments beyond what can be learned from clinical data, according to a health data specialist who presented a session during the Academy of Managed Care Pharmacy 2017 Nexus meeting.

Outcomes-based risk sharing contracts will continue to become more common as health plans, providers, and drug manufacturers realize the benefits of these arrangements, according to speakers at a session of the Academy of Managed Care Pharmacy 2017 Nexus meeting.

At a session during the Academy of Managed Care Pharmacy 2017 Nexus meeting, a public policy expert argued that despite all of the news surrounding the Affordable Care Act (ACA), the US healthcare system may not see fundamental changes anytime soon.

In light of recent guidance from the FDA on appropriate communications between payers and drug manufacturers prior to a drug's approval, a panel of stakeholders at the Academy of Managed Care Pharmacy 2017 Nexus meeting, discussed how these new guidelines can raise as many questions as they answer.

Experts from Express Scripts discussed how data on consumer behavior can be used to improve health outcomes and control the costs of care during a session of the Academy of Managed Care Pharmacy 2017 Nexus meeting.

A session at the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus meeting discussed the implications of recent legislative and regulatory changes in healthcare at the federal and state levels.

Aimee Tharaldson, PharmD, of Express Scripts kicked off the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus, held October 16-19 in Dallas, Texas, with a presentation on the pipeline of specialty pharmaceuticals in development.

Immune checkpoint inhibitors have become an important tool for treating cancer, but a new review finds their use is associated with a higher risk of endocrine dysfunctions like thyroid imbalances.

Clinical trials researching cancer therapies should be more inclusive of a broader range of patients, according to the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research.

On consecutive days, the FDA announced 2 more strategies to help novel drugs reach more patients. One plan will encourage competition by providing more guidance to developers of complex generics, while the other will make it easier for physicians to treat patients with investigational products through the expanded access program.

In recent years, the number of nursing home residents has decreased, but the number of complaints about nursing homes has increased by 33%, a new report finds. While most are promptly investigated, some states are falling behind on completing follow-up investigations within required timeframes.

Coverage of technology developments at the 77th Scientific Sessions of the American Diabetes Association (ADA) and the annual meeting of the American Association of Diabetes Educators (AADE).

Novo Nordisk announced that the FDA has approved its insulin aspart injection Fiasp, which can rapidly improve glycemic control at mealtimes for patients with type 1 and type 2 diabetes.

Not only do patients with cancer incur higher costs when treated in the hospital outpatient setting compared with community oncology practices, they also have higher rates of emergency department visits, according to a recent study.

After examining over 1000 cases of high-grade gliomas in children and young adults, researchers have split these rare brain tumors into at least 10 different subtypes, which could help clinicians choose and deliver more effective treatments.

HHS has challenged mobile app developers and other technology innovators to create an intervention to promote nutrition, health, and fitness among low-income children and families.

A new case study of 12 advanced primary care practices found that none provided comprehensive cancer survivorship care, which the authors attributed to insufficient information systems and difficulties identifying survivors.

The FDA has announced the 9 companies that will participate in a pilot precertification program to speed the approval of digital health software.

Time is running out for Congress to reauthorize funding for the Children’s Health Insurance Program (CHIP) before it expires on September 30, leaving states and families to prepare for possible coverage reductions and higher premiums.

When Donald Trump was elected president in November 2016, repealing the Affordable Care Act (ACA) suddenly became an attainable goal for Republicans in Congress, though it ultimately did not come to fruition as they had hoped. Here, we look back at the legislative twists and turns of ACA repeal efforts in 2017.

Senate Majority Leader Mitch McConnell, R-Kentucky, announced that the Senate would not vote on the bill to repeal the Affordable Care Act (ACA) in light of a shortage of votes.

Among women treated at health centers receiving federal funding under Title X, the proportion receiving cervical cancer screening tests declined significantly from 2005 to 2015, according to new research.

A new analysis finds that the mortality rate from chronic respiratory diseases has risen by almost 30% between 1980 and 2014 in the United States, and that data reflect significant differences in death rates across counties and regions.

While the FDA’s approval of the immunotherapy tisagenlecleucel represents a landmark in the oncology field, the treatment is far from being a cure and should be viewed in context of its $475,000 price tag, a group of oncologists wrote in a commentary published in JAMA.

A new study finds that participating in the Supplemental Nutrition Assistance Program (SNAP) is associated with significantly lower healthcare expenditures, pointing to the role of social determinants like food insecurity as contributors to health spending.

When immune-related adverse events arise from nivolumab, it may indicate that the therapy is having greater efficacy against non—small-cell lung cancer (NSCLC), as a new study demonstrates a link between these events and improved survival outcomes.